Announcement on the Proposed Reappointment of Accounting Firm
Shandong WoHua Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") announces that the board of directors and all directors guarantee that the content of this announcement does not contain any false records, misleading statements, or major omissions, and bear individual and joint responsibility for the authenticity, accuracy, and completeness of its content.
Important Content Reminder:
- Proposed Accounting Firm Name: Zhongxi Accounting Firm (Special General Partnership)
The Company held the seventh meeting of the eighth board of directors on January 19, 2026, where it reviewed and approved the proposal on the reappointment of the accounting firm, agreeing to appoint Zhongxi Accounting Firm (Special General Partnership) as the Company's financial audit institution and internal control audit institution for the year 2026, and to submit this matter for review at the Company's 2025 annual general meeting of shareholders. The relevant matters are announced as follows:
I. Basic Information of the Proposed Accounting Firm
(1) Institution Information
- Basic Information
- Firm Name: Zhongxi Accounting Firm (Special General Partnership)
- Establishment Date: November 28, 2013
- Organizational Form: Special General Partnership
- Registered Address: Room 1101, 11th Floor, No. 11, Chongwenmen Outer Street, Dongcheng District, Beijing
- Chief Partner: Zhang Zenggang
As of the end of 2024, Zhongxi has 102 partners, 442 certified public accountants, and a total of 1,456 employees, with 330 certified public accountants having signed audit reports for securities service businesses. In 2024, the firm served over 8,800 clients, achieving total revenue of 418.4583 million yuan (audited), of which audit service revenue was 365.7589 million yuan (audited) and securities service revenue was 122.6014 million yuan (audited). The firm served 40 listed company clients in 2024.